|
| Contact inhibition against senescence |
|
https://doi.org/10.18632/oncotarget.2446
Peiqing Sun
|
| 7212-7213 |
|
| mTORC2 takes the longevity stAGE |
|
https://doi.org/10.18632/oncotarget.2457
Dudley W. Lamming
|
| 7214-7215 |
|
| Targeting STAT6 in PMBL |
|
https://doi.org/10.18632/oncotarget.2447
Karen Leroy, Anais Pujals, and Laura Pelletier
|
| 7216 |
|
| Molecular pathways and targets in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2406
Emma Shtivelman, Tomasz M. Beer, and Christopher P. Evans
|
| 7217-7259 |
|
| TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis |
|
https://doi.org/10.18632/oncotarget.2428
Sudhakar V. Nuti, Gil Mor, Peiyao Li, and Gang Yin
|
| 7260-7271 |
|
| Altered Mucins MUC Trafficking in Benign and Malignant Conditions |
|
https://doi.org/10.18632/oncotarget.2370
Suhasini Joshi, Sushil Kumar, Amit Choudhury, Moorthy P. Ponnusamy, and Surinder K. Batra
|
| 7272-7284 |
|
| The structural basis for cancer treatment decisions |
|
https://doi.org/10.18632/oncotarget.2439
Ruth Nussinov, Hyunbum Jang, and Chung-Jung Tsai
|
| 7285-7302 |
|
| Acetylationdefective mutants of Pparγ are associated with decreased lipid synthesis in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2371
Lifeng Tian, Chenguang Wang, Fred K. Hagen, Michael Gormley, Sankar Addya, Raymond Soccio, Mathew C. Casimiro, Jie Zhou, Michael J. Powell, Ping Xu, Haiteng Deng, Anthon A. Sauve, and Richard G. Pestell
|
| 7303-7315 |
|
| AP4 is required for mitogen and cMYCinduced cell cycle progression |
|
https://doi.org/10.18632/oncotarget.2348
Rene Jackstadt, and Heiko Hermeking
|
| 7316-7327 |
|
| Overcoming EMTassociated resistance to anticancer drugs via Src/FAK pathway inhibition |
|
https://doi.org/10.18632/oncotarget.2397
Catherine Wilson, Katrina Nicholes, Daisy Bustos, Eva Lin, Qinghua Song, Jean-Philippe Stephan, Donald S. Kirkpatrick, and Jeff Settleman
|
| 7328-7341 |
|
| Epigenetic suppression of EGFR signaling in GCIMP+ glioblastomas |
|
https://doi.org/10.18632/oncotarget.2350
Jie Li, Zachary J. Taich, Amit Goyal, David Gonda, Johnny Akers, Bandita Adhikari, Kunal Patel, Scott Vandenberg, Wei Yan, Zhaoshi Bao, Bob S. Carter, Renzhi Wang, Ying Mao, Tao Jiang, and Clark C. Chen
|
| 7342-7356 |
|
| Nuclear Eg5 kinesin spindle protein expression predicts docetaxel response and prostate cancer aggressiveness |
|
https://doi.org/10.18632/oncotarget.1985
Michel D. Wissing, Ellen S. De Morrée, Vincent O. Dezentjé, Jeroen T. Buijs, Ronald R. De Krijger, Vincent T.H.B.M. Smit, Wytske M. Van Weerden, Hans Gelderblom, and Gabri van der Pluijm
|
| 7357-7367 |
|
| Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive Bcell nonhodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.2255
Qingqing Cai, Yiming Chen, Dehui Zou, Liang Zhang, Maria Badillo, Shouhao Zhou, Elyse Lopez, Wenqi Jiang, Huiqiang Huang, Tongyu Lin, Jorge Romaguera, and Michael Wang
|
| 7368-7380 |
|
| 18 FDGPET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation |
|
https://doi.org/10.18632/oncotarget.2290
Constantin Lapa, Katharina Lückerath, Uwe Malzahn, Samuel Samnick, Herrmann Einsele, Andreas K. Buck, Ken Herrmann, and Stefan Knop
|
| 7381-7391 |
|
| NM23H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment |
|
https://doi.org/10.18632/oncotarget.1912
Yi-Fen Wang, Chun-Ju Chang, Jen-Hwey Chiu, Chin-Ping Lin, Wing-Yin Li, Shyue-Yih Chang, Pen-Yuan Chu, Shyh-Kuan Tai, and Yu-Jen Chen
|
| 7392-7405 |
|
| Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1558
Brianne Hill, Jason De Melo, Judy Yan, Anil Kapoor, Lizhi He, Jean-Claude Cutz, Xiangchang Feng, Nazihah Bakhtyar, and Damu Tang
|
| 7406-7419 |
|
| Applicability of the methylated CpG sites of paired box 5 PAX5 promoter for prediction the prognosis of gastric cancer |
|
https://doi.org/10.18632/oncotarget.1973
Jingyu Deng, Han Liang, Rupeng Zhang, Qiuping Dong, Yachao Hou, Jun Yu, Daiming Fan, and Xishan Hao
|
| 7420-7430 |
|
| Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROSdependent synergism and signaling crosstalk |
|
https://doi.org/10.18632/oncotarget.2008
Wenqiang Cao, Xiaoling Li, Shanyuan Zheng, Wenjie Zheng, Yum-shing Wong, and Tianfeng Chen
|
| 7431-7445 |
|
| TRIM8 antiproliferative action against chemoresistant renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2081
Mariano Francesco Caratozzolo, Alessio Valletti, Margherita Gigante, Italia Aiello, Francesca Mastropasqua, Flaviana Marzano, Pasquale Ditonno, Giuseppe Carrieri, Hélène Simonnet, Anna Maria D’Erchia, Elena Ranieri, Graziano Pesole, Elisabetta Sbisà , and Apollonia Tullo
|
| 7446-7457 |
|
| High mobility group Box1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression |
|
https://doi.org/10.18632/oncotarget.2150
Zhenghong Zuo, Xun Che, Yulei Wang, Bowen Li, Jingxia Li, Wei Dai, Charles P. Lin, and Chuanshu Huang
|
| 7458-7470 |
|
| Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.2166
Peng Liu, Zhipeng Wang, Sarah Brown, Vinodh Kannappan, Patricia Erebi Tawari, Wenguo Jiang, Juan M. Irache, James Z. Tang, Stephen Britland, Angel L. Armesilla, John L. Darling, Weiguang Wang, and Weiguang Wang Wang
|
| 7471-7485 |
|
| EMT and EGFR in CTCs cytokeratin negative nonmetastatic breast cancer |
|
https://doi.org/10.18632/oncotarget.2217
Maria J. Serrano, Francisco G. Ortega, Maria J. Alvarez-Cubero, Rosa Nadal, Pedro Sanchez-Rovira, Marta Salido, MarÃa RodrÃguez, Jose L. GarcÃa-Puche, Miguel Delgado-Rodriguez, Francisco Solé, Maria A. GarcÃa, Macarena Perán, Rafael Rosell, Juan A. Marchal, and Jose A. Lorente
|
| 7486-7497 |
|
| Aurora kinase a suppresses metabolic stressinduced autophagic cell death by activating mTOR signaling in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2241
Ling-Zhi Xu, Zi-Jie Long, Fei Peng, Yang Liu, Jie Xu, Chang Wang, Lei Jiang, Tao Guo, Muhammad Kamran, Si-Si Li, Chun-Li Wang, Hong-Jiang Wang, Yong-Fu Zhao, Xian-Yao Wan, and Quentin Liu
|
| 7498-7511 |
|
| Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair |
|
https://doi.org/10.18632/oncotarget.2258
Peng Lv, Yue Wang, Jie Ma, Zheng Wang, Jing-Li Li, Christopher S. Hong, Zhengping Zhuang, and Yi-Xin Zeng
|
| 7512-7524 |
|
| Beclin1independent autophagy positively regulates internal ribosomal entry sitedependent translation of hypoxiainducible factor 1α under nutrient deprivation |
|
https://doi.org/10.18632/oncotarget.2265
Ching-An Wu, Duen-Yi Huang, and Wan-Wan Lin
|
| 7525-7539 |
|
| Arraybased genomewide RNAi screening to identify shRNAs that enhance p53related apoptosis in human cancer cells |
|
https://doi.org/10.18632/oncotarget.2272
Masashi Idogawa, Tomoko Ohashi, Jun Sugisaka, Yasushi Sasaki, Hiromu Suzuki, and Takashi Tokino
|
| 7540-7548 |
|
| Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NFκB signaling |
|
https://doi.org/10.18632/oncotarget.2273
Patty C.H. Cai, Lei Shi, Vincent W.S. Liu, Hermit W.M. Tang, Iris J. Liu, Thomas H.Y. Leung, Karen K.L. Chan, Judy W.P. Yam, Kwok-Ming Yao, Hextan Y.S. Ngan, and David W. Chan
|
| 7549-7562 |
|
| βTrCP controls the lysosomemediated degradation of CDK1 whose accumulation correlates with tumor malignancy |
|
https://doi.org/10.18632/oncotarget.2274
JoaquÃn Herrero-Ruiz, Mar Mora-Santos, Servando Giráldez, Carmen Sáez, Miguel Ã. Japón, Maria Tortolero, and Francisco Romero
|
| 7563-7574 |
|
| Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells |
|
https://doi.org/10.18632/oncotarget.2243
Gloria Bonuccelli, Sofia Avnet, Giulia Grisendi, Manuela Salerno, Donatella Granchi, Massimo Dominici, Katsuyuki Kusuzaki, and Nicola Baldini
|
| 7575-7588 |
|
| Osteoblastderived WISP1 increases VCAM1 expression and enhances prostate cancer metastasis by downregulating miR126 |
|
https://doi.org/10.18632/oncotarget.2280
Huai-Ching Tai, An-Chen Chang, Hong-Jeng Yu, Chao-Yuan Huang, Yu-Chieh Tsai, Yu-Wei Lai, Hui-Lung Sun, Chih-Hsin Tang, and Shih-Wei Wang
|
| 7589-7598 |
|
| MicroRNA145 targets MUC13 and suppresses growth and invasion of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2281
Sheema Khan, Mara C. Ebeling, Mohd S. Zaman, Mohammed Sikander, Murali M. Yallapu, Neeraj Chauhan, Ashley M. Yacoubian, Stephen W. Behrman, Nadeem Zafar, Deepak Kumar, Paul A. Thompson, Meena Jaggi, and Subhash C. Chauhan
|
| 7599-7609 |
|
| Silencing of miRNA148a by hypermethylation activates the integrinmediated signaling pathway in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2282
Hsin-Pai Li, Hsin-Yi Huang, Yi-Ru Lai, Jing-Xuan Huang, Kai-Ping Chang, Chuen Hsueh, and Yu-Sun Chang
|
| 7610-7624 |
|
| NMycinduced upregulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation |
|
https://doi.org/10.18632/oncotarget.2283
Zheng Zhang, Malika Faouzi, Junhao Huang, Dirk Geerts, Haijie Yu, Andrea Fleig, and Reinhold Penner
|
| 7625-7634 |
|
| Selective targeting of KRASMutant cells by miR126 through repression of multiple genes essential for the survival of KRASMutant cells |
|
https://doi.org/10.18632/oncotarget.2284
Toshifumi Hara, Matthew F. Jones, Murugan Subramanian, Xiao Ling Li, Oliver Ou, Yuelin Zhu, Yuan Yang, Lalage M. Wakefield, Perwez S. Hussain, Jochen Gaedcke, Thomas Ried, Ji Luo, Natasha J. Caplen, and Ashish Lal
|
| 7635-7650 |
|
| MicroRNAmediated downregulation of NKG2D ligands contributes to glioma immune escape |
|
https://doi.org/10.18632/oncotarget.2287
Paula Codo, Michael Weller, Gunter Meister, Emese Szabo, Alexander Steinle, Marietta Wolter, Guido Reifenberger, and Patrick Roth
|
| 7651-7662 |
|
| CLDN3 inhibits cancer aggressiveness via WntEMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2288
Lei Jiang, Yi-Dong Yang, Li Fu, Weiqi Xu, Dabin Liu, Qiaoyi Liang, Xiang Zhang, Lixia Xu, Xin-Yuan Guan, Bin Wu, Joseph J.Y. Sung, and Jun Yu
|
| 7663-7676 |
|
| A central role for TRPS1 in the control of cell cycle and cancer development |
|
https://doi.org/10.18632/oncotarget.2291
Lele Wu, Yuzhi Wang, Yan Liu, Shiyi Yu, Hao Xie, Xingjuan Shi, Sheng Qin, Fei Ma, Tuan Zea Tan, Jean Paul Thiery, and Liming Chen
|
| 7677-7690 |
|
| Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI73 |
|
https://doi.org/10.18632/oncotarget.2296
Frankie Lam, Abdullahi Y. Abbas, Hao Shao, Theodosia Teo, Julian Adams, Peng Li, Tracey D. Bradshaw, Peter M. Fischer, Elisabeth Walsby, Chris Pepper, Yi Chen, Jian Ding, and Shudong Wang
|
| 7691-7704 |
|
| Expression and functions of galectin7 in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2299
Marilyne Labrie, Maria Claudia Vladoiu, Andrée-Anne Grosset, Louis Gaboury, and Yves St-Pierre
|
| 7705-7721 |
|
| Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway resulting in increased antioxidant defense |
|
https://doi.org/10.18632/oncotarget.2300
Angelo D’Alessandro, Ivano Amelio, Celia R. Berkers, Alexey Antonov, Karen H. Vousden, Gerry Melino, and Lello Zolla
|
| 7722-7733 |
|
| Amphipathic tailanchoring peptide is a promising therapeutic agent for prostate cancer treatment |
|
https://doi.org/10.18632/oncotarget.2301
Gejing De, Jae-Kyun Ko, Tao Tan, Hua Zhu, Haichang Li, and Jianjie Ma
|
| 7734-7747 |
|
| The microRNA23b/27b/241 cluster is a disease progression marker and tumor suppressor in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2294
Yusuke Goto, Satoko Kojima, Rika Nishikawa, Hideki Enokida, Takeshi Chiyomaru, Takashi Kinoshita, Masayuki Nakagawa, Yukio Naya, Tomohiko Ichikawa, and Naohiko Seki
|
| 7748-7759 |
|
| Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR494 |
|
https://doi.org/10.18632/oncotarget.2305
Yifeng Bai, Yanqin Sun, Juan Peng, Hongzhan Liao, Hongyi Gao, Ying Guo, and Linlang Guo
|
| 7760-7775 |
|
| Annexin A4 induces platinum resistance in a chlorideand calciumdependent manner |
|
https://doi.org/10.18632/oncotarget.2306
Akiko Morimoto, Satoshi Serada, Takayuki Enomoto, Ayako Kim, Shinya Matsuzaki, Tsuyoshi Takahashi, Yutaka Ueda, Kiyoshi Yoshino, Masami Fujita, Minoru Fujimoto, Tadashi Kimura, and Tetsuji Naka
|
| 7776-7787 |
|
| The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination |
|
https://doi.org/10.18632/oncotarget.2307
De-Wei Lai, Shing-Hwa Liu, Anna Isabella Karlsson, Wen-Jane Lee, Keh-Bin Wang, Yi-Ching Chen, Chin-Chang Shen, Sheng-Mao Wu, Chia-Yu Liu, Hsing-Ru Tien, Yen-Chun Peng, Yee-Jee Jan, Te-Hsin Chao, Keng-Hsin Lan, Jack L. Arbiser, and Meei-Ling Sheu
|
| 7788-7804 |
|
| Clusterin inhibition using OGX011 synergistically enhances zoledronic acid activity in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.2308
Francois Lamoureux, Marc Baud’huin, Benjamin Ory, Romain Guiho, Amina Zoubeidi, Martin Gleave, Dominique Heymann, and Françoise Rédini
|
| 7805-7819 |
|
| Neddylation pathway is upregulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target |
|
https://doi.org/10.18632/oncotarget.2309
Qiang Gao, Guang-Yang Yu, Jie-Yi Shi, Li-Hui Li, Wen-Juan Zhang, Zhi-Chao Wang, Liu-Xiao Yang, Meng Duan, Hu Zhao, Xiao-Ying Wang, Jian Zhou, Shuang-Jian Qiu, Lak Shin Jeong, Li-Jun Jia, and Jia Fan
|
| 7820-7832 |
|
| Coordination of cell cycle migration and stem celllike activity in breast cancer |
|
https://doi.org/10.18632/oncotarget.2312
Rebecca Lamb, Michael P. Lisanti, Robert B. Clarke, and Göran Landberg
|
| 7833-7842 |
|
| A highly efficient tumorinfiltrating MDSC differentiation system for discovery of antineoplastic targets which circumvents the need for tumor establishment in mice |
|
https://doi.org/10.18632/oncotarget.2279
Therese Liechtenstein, Noemi Perez-Janices, Maria Gato, Fabio Caliendo, Grazyna Kochan, Idoia Blanco-Luquin, Frederick Arce, David Guerrero-Setas, Joaquin Fernandez-Irigoyen, Enrique Santamaria, Karine Breckpot, and David Escors
|
| 7843-7857 |
|
| ÂIntegrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer |
|
https://doi.org/10.18632/oncotarget.2313
Nicole M. A. White-Al Habeeb, Linh T. Ho, Ekaterina Olkhov-Mitsel, Ken Kron, Vaijayanti Pethe, Melanie Lehman, Lidija Jovanovic, Neil Fleshner, Theodorus van der Kwast, Colleen C. Nelson, and Bharati Bapat
|
| 7858-7869 |
|
| Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2dependent ubiquitin proteasome pathway in TGFβ receptor degradation |
|
https://doi.org/10.18632/oncotarget.2317
Hsien-Yeh Hsu, Tung-Yi Lin, Yu-Chung Wu, Shu-Ming Tsao, Pai-An Hwang, Yu-Wei Shih, and Jason Hsu
|
| 7870-7885 |
|
| Assessment of the effect of sphingosine kinase inhibitors on apoptosisunfolded protein response and autophagy of Tcell acute lymphoblastic leukemia cells; indications for novel therapeutics |
|
https://doi.org/10.18632/oncotarget.2318
Cecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, Francesca Chiarini, Mirella Falconi, Fraia Melchionda, Andrea Pession, Alice Bertaina, Franco Locatelli, James A. McCubrey, Dong Jae Beak, Robert Bittman, Susan Pyne, Nigel J. Pyne, and Alberto M. Martelli
|
| 7886-7901 |
|
| miR200c overexpression is associated with better efficacy of EGFRTKIs in nonsmall cell lung cancer patients with EGFR wildtype |
|
https://doi.org/10.18632/oncotarget.2302
Jiayu Li, Xuefei Li, Shengxiang Ren, Xiaoxia Chen, Yishi Zhang, Fei Zhou, Mingchuan Zhao, Chao Zhao, Xiu Chen, Ningning Cheng, Yinmin Zhao, Caicun Zhou, and Fred R. Hirsch
|
| 7902-7916 |
|
| Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.1421
Iawen Hsu, Chiuan-Ren Yeh, Spencer Slavin, Hiroshi Miyamoto, George Netto, Yu-Chieh Tsai, Mesut Muyan, Xue-Ru Wu, and Shuyuan Yeh
|
| 7917-7935 |
|
| Mutant NRASQ61 shares signaling similarities across various cancer types – potential implications for future therapies |
|
https://doi.org/10.18632/oncotarget.2326
Igor Vujic, Christian Posch, Martina Sanlorenzo, Adam J. Yen, Aaron Tsumura, Andrew Kwong, Valentin Feichtenschlager, Kevin Lai, Douglas V. Arneson, Klemens Rappersberger, and Susana M. Ortiz-Urda
|
| 7936-7944 |
|
| FAK Inhibition with Small Molecule Inhibitor Y15 Decreases Viability Clonogenicity and Cell Attachment in Thyroid Cancer Cell Lines and Synergizes with Targeted Therapeutics |
|
https://doi.org/10.18632/oncotarget.2381
Shalana O’Brien, Vita M. Golubovskaya, Jeffrey Conroy, Song Liu, Dan Wang, Biao Liu, and William G. Cance
|
| 7945-7959 |
|
| Mutations in CIC and IDH1 cooperatively regulate 2hydroxyglutarate levels and cell clonogenicity |
|
https://doi.org/10.18632/oncotarget.2401
Suganthi Chittaranjan, Susanna Chan, Cindy Yang, Kevin C. Yang, Vincent Chen, Annie Moradian, Marlo Firme, Jungeun Song, Nancy E. Go, Michael D. Blough, Jennifer A. Chan, Gregory J. Cairncross, Sharon M. Gorski, Gregg B. Morin, Stephen Yip, and Marco A. Marra
|
| 7960-7979 |
